terventions (pharmacologic and non-pharmacologic), 6) types of outcome measures (self-reported, performance-based, examination, imaging), and 7) considerations in the statistical analysis of data. Participants will complete an exercise that designs a clinical trial for symptom and structure modification in patients with knee osteoarthritis.
ROLE OF MATRIX METALLOPROTEINASES IN CARTILAGE AND BONE DURING SKELETAL REMODELING
Stephen M Krane Matrix metalloproteinases (MMPs) are expressed in cartilage during embryonic development and later during remodeling. Mmp9, although not a collagenase is expressed early in embryogenesis during endochondral ossification and Mmp9 deficiency in mice results in abnormalities that affects growth plates. Mmp13 (collagenase-3), a highly expressed collagenolytic MMP in cartilage and in developing and remodeling bone, also has a role in the joint tissue destruction that is a major feature of various forms of human arthritis. We have targeted a null mutation in mouse
Mmp13 that resulted in a profound embryonic and adult skeletal phenotype characterized by abnormal growth plates and delayed ossification. During embryonic development at the earliest stage examined, Mmp13 -/-mice had growth plates in long bones almost double in length, accounted for by increases in the zone of hypertrophy. Mmp13, produced by chondrocytes but not by osteoclasts/chondroclasts, is particularly effective in proteolysis of type II compared to type I collagen. Using antibodies that detect epitopes in the specific proteolytic fragments, we obtained evidence for Mmp13 cleavage of type II collagen in vivo in wt mice, but not in Mmp13-/-mice. It is thus unlikely that other Mmps compensate for the loss of Mmp13 function in cartilage. The delay in ossification, so prominent in 15.5 dpc Mmp13 -/-embryos, is largely transient and older Mmp13 -/-mice have increased bone deposition. Mmp8 is also expressed in newborn Mmp13 -/-and wt skeletons but Mmp '-/-mice have normal skeletons. Type X collagen is also a substrate for MMP1 and Mmp13. The area of type X collagen deposition was significantly increased in growth plates from Mmp13-/-mice, consistent with decreased proteolysis. Increased synthesis of type X collagen could also contribute. Based on our results, Mmp13 has a critical role in regulating events in the growth plate beginning in embryonic development. Deficiency of Mmpl 3 with failure to normally resorb collagens in the cartilage ECM profoundly affects cellular activities that underlie differentiation of hypertrophic chondrocytes that persist in newborn and adult mice. The phenotype of / adult Mmp13--mice with increased length of growth plates, increased numbers of chondrocytes and distortion of alignment of the rows of chondrocytes thus has features of a chondrodysplasia. Articular cartilage is also affected. It is pertinent that a form of human chondrodysplasia, the Missouri variant of spondyloepimetaphyseal dysplasia is caused by a mutation in MMP13 that results in misfolding, intracellular degradation and MMP13 deficiency. Human mutations in MMP2 also result in a skeletal phenotype (nodulosis, osteolysis and arthropathy) distinct from that in MMP13 mutations. Bone is abnormal in Mmp2-null mice but the mice do not show other features of the human mutation.
INTEGRIN-SYNDECAN CO-OPERATION GOVERNS THE ASSEMBLY OF SIGNALLING COMPLEXES DURING CELL MIGRATION

Martin J Humphries
Cell adhesion receptors play a fundamental role in integrating the extracellular matrix with cell signalling complexes, and thereby control diverse, distal events in metazoa such as cell fate and tissue structure. Within cells, adhesion signalling occurs at focal sites and involves the formation and maturation of discrete adhesion complexes. The sequential modulation of Rho family GTPase activity is a critical control point determining the efficacy of adhesion signalling. Adhesive responses to the extracellular matrix protein, fibronectin (FN), which are mediated by members of the integrin and syndecan adhesion receptor families, have served as a prototype for many of these studies, and the outcomes are generally applicable to a large majority of adhesive responses. Interestingly, cells plated onto a FN fragment that binds the integrin ~51~1 are able to spread but fail to form adhesion complexes or fully organise actin into bundled stress fibres unless costimulated with a distinct FN fragment that binds syndecan-4. Engagement of syndecan-4 in such pre-spread cells recapitulates the Rho family activation profiles observed during spreading on whole FN. We have found that adhesion to a ligand of ~51~1 alone does not activate one member of the Rho family, Racl, indicating that engagement of syndecan-4 is an absolute requirement for this key signalling event. In related work, we have examined differences in the mechanism of adhesion complex formation mediated by different FN-binding integrins, ~41~1 and ~51~1. Two signalling differences were found. First, while ~51~1 required a proteoglycan co-receptor (syndecan-4), ~41~1 did not. Second, adhesion contact formation via ~51~1 required PKC~ activation, but only basal PKC~ activity was observed following adhesion via ~41~1. These findings demonstrate that different integrins can signal to induce focal adhesion formation and migration by different mechanisms, and provide insights into the ways that the extracellular environment controls cell morphology and movement.
NOVEL GENETIC MARKERS OF OSTEOARTHRITIS
John Loughlin
Early cross-sectional and longitudinal studies demonstrated familial clustering of primary osteoarthritis, implying a genetic component to the disease. However, such clustering could also be the result of shared environmental factors within a family. Twin studies have since been performed that demonstrate a clear heritability to OA at a number of skeletal sites, including hands, hips, knees and the spine [1] . Other epidemiological studies have also been performed investigating the nature of OA transmittance from parents to offspring and the prevalence of disease between relative-pairs, particularly siblings. These studies have confirmed a major genetic component to OA, which is transmitted in a non-Mendelian, complex manner. It has gradually become apparent that the nature of the genetic risk is likely to vary somewhat between different skeletal sites and may also vary between the sexes, although this latter observation is based on a small number of studies and needs further investigation to confirm it's veracity. With a genetic component established the next step was a hunt for the risk alleles. Investigators initially focussed on genes encoding the major structural components of the cartilage extracellular matrix, such as aggrecan and type II collagen. These studies did not provide the expected breakthroughs and prompted a re-think on the nature of OA susceptibility: instead of the cartilage matrix being poorly constructed could the susceptibility be
